April Featured Cancer Clinical Trials

A Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia
SEGE 1913 | 13-1393
Disease(s): Leukemia, Acute Myeloid (AML)
See full trial information

A Phase III Randomized Clinical Trial of Pembrolizumab (MK-3475) versus Paclitaxel, Docetaxel or Vinflunine in Subjects with Recurrent or Progressive Metastatic Urothelial Cancer
MRK 1814 | 15-031
Disease(s): Bladder, Urethral
See full trial information

A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected State III Colon Cancer
CALGB 80702 | CC979
Disease: Colorectal
See full trial information

A randomized phase II trial for patients with p16 positive, non-smoking associated, locoregionally advanced oropharyngeal cancer
NRG HN002 | 15-086
Disease: Head & Neck
See full trial information

A Phase II Clinical Trial of Single Agent Pembrolizumab (MK-3475) in Subjects with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Who Have Failed Platinum and Cetuximab
MRK 1314 | 14-1442
Disease: Head & Neck
See full trial information

Phase I Dose Escalation Study of Stereotactic Body Radiotherapy for p16 Negative Squamous Cell Carcinoma of the Head and Neck in High Risk Patients Who are Ineligible/Refuse Standard of Care Therapy
CASE 8314 | 15-006
Disease: Head & Neck
See full trial information

Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescent and Adult Patients with Hematological Malignancies
GMCL 1Z14 | 14-963
Disease: Hematologic Malignancy
See full trial information

A phase 2, multicenter, single-arm, open-label study of pomalidomide in combination with low-dose dexamethasone in subjects with relapsed or refractory Multiple Myeloma following lenalidomide-based therapy in the second-line setting
CLGN 1A14 | 14-1374
Disease: Multiple Myeloma
See full trial information

A Multicenter Phase 2 Study of Single-agent Filanesib (ARRY-520) in Patients With Advanced Multiple Myeloma
ARRY 1A14 | 14209
Disease: Multiple Myeloma
See full trial information

Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Combination with Lenalidomide or Oral Cyclophosphamide in Patients with Newly Diagnosed Multiple Myeloma
ONYX 1A13 | 14-231
Disease: Multiple Myeloma
See full trial information

Phase II Randomized Study of survival rate of two different drugs in MDS Patients with Low and Intermediate-1 Risk Disease Transfusion-Dependent versus Best Supportive Care (BSC) in MDS Patients with Low and Intermediate-1 Risk Disease Transfusion-Independent
MDCC 1914 | 14-1479
Disease: Myelodysplastic Syndrome (MDS)
See full trial information

A Phase 1b/2 Study of OMP-59R5 in Combination with Nab-Paclitaxel and Gemcitabine in Subjects with Previously Untreated Stage IV Pancreatic Cancer ALPINE: Antibody therapy in first-Line Pancreatic cancer Investigating anti-Notch Efficacy and safety
OMP 1213 | 14-124
Disease: Pancreas
See full trial information

A Phase I single arm study to assess the safety and efficacy of Pomalidomide in patients with bleeding due to Hereditary Hemorrhagic Telangiectasia and Refractory Angiodysplasia
CASE 4Z14 | 14-786
Diseases: Telangiectasia, Vascular Ectasia
See full trial information

Search our clinical trials database to see all currently open cancer trials.